(Q36721012)

English

Switching to Tenofovir Alafenamide, Coformulated With Elvitegravir, Cobicistat, and Emtricitabine, in HIV-Infected Patients With Renal Impairment: 48-Week Results From a Single-Arm, Multicenter, Open-Label Phase 3 Study

scientific article published on 30 November 2015

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Switching to Tenofovir Alafenamide, Coformulated With Elvitegravir, Cobicistat, and Emtricitabine, in HIV-Infected Patients With Renal Impairment: 48-Week Results From a Single-Arm, Multicenter, Open-Label Phase 3 Study (English)

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

multicenter clinical trial

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Ploenchan Chetchotisakd

12

object named as

Ploenchan Chetchotisakd

0 references

3

object named as

Joseph Gathe

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

author name string

Anton Pozniak

1

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Jose R Arribas

2

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Samir K Gupta

4

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Frank A Post

5

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Mark Bloch

6

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Anchalee Avihingsanon

7

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Gordon Crofoot

8

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Paul Benson

9

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Kenneth Lichtenstein

10

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Moti Ramgopal

11

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Joseph M Custodio

13

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Michael E Abram

14

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Xuelian Wei

15

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Andrew Cheng

16

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Scott McCallister

17

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Devi SenGupta

18

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Marshall W Fordyce

19

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

GS-US-292-0112 Study Team

20

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

language of work or name

0 references

publication date

30 November 2015

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Journal of Acquired Immune Deficiency Syndromes

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

71

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

5

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

530-537

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Tenofovir alafenamide versus tenofovir disoproxil fumarate, coformulated with elvitegravir, cobicistat, and emtricitabine, for initial treatment of HIV-1 infection: two randomised, double-blind, phase 3, non-inferiority trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4804743

30 September 2017

Clinical practice guideline for the management of chronic kidney disease in patients infected with HIV: 2014 update by the HIV Medicine Association of the Infectious Diseases Society of America

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4804743

30 September 2017

Role of traditional risk factors and antiretroviral drugs in the incidence of chronic kidney disease, ANRS CO3 Aquitaine cohort, France, 2004-2012

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4804743

30 September 2017

The kidney in HIV infection: beyond HIV-associated nephropathy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4804743

30 September 2017

The new invincibles: HIV screening among older adults in the U.S.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4804743

30 September 2017

Estimating glomerular filtration rate from serum creatinine and cystatin C.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4804743

30 September 2017

Baseline kidney function as predictor of mortality and kidney disease progression in HIV-positive patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4804743

30 September 2017

Association of tenofovir exposure with kidney disease risk in HIV infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4804743

30 September 2017

Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes. A collaborative meta-analysis of general and high-risk population cohorts

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4804743

30 September 2017

Systematic review and meta-analysis: renal safety of tenofovir disoproxil fumarate in HIV-infected patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4804743

30 September 2017

Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4804743

30 September 2017

Association between kidney function and albuminuria with cardiovascular events in HIV-infected persons

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4804743

30 September 2017

Chronic administration of tenofovir to rhesus macaques from infancy through adulthood and pregnancy: summary of pharmacokinetics and biological and virological effects.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4804743

30 September 2017

Chronic kidney disease in HIV infection: an urban epidemic

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4804743

30 September 2017

The effect of lopinavir/ritonavir on the renal clearance of tenofovir in HIV-infected patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4804743

30 September 2017

Highly active antiretroviral therapy and the epidemic of HIV+ end-stage renal disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4804743

30 September 2017

Selective intracellular activation of a novel prodrug of the human immunodeficiency virus reverse transcriptase inhibitor tenofovir leads to preferential distribution and accumulation in lymphatic tissue

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4804743

30 September 2017

Proteinuria and other markers of chronic kidney disease: a position statement of the national kidney foundation (NKF) and the national institute of diabetes and digestive and kidney diseases (NIDDK)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4804743

30 September 2017

Tenofovir use is associated with a reduction in calculated glomerular filtration rates in the Swiss HIV Cohort Study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4804743

5 September 2018

Greater tenofovir-associated renal function decline with protease inhibitor-based versus nonnucleoside reverse-transcriptase inhibitor-based therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4804743

5 September 2018

Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts

1 reference

https://pubmed.ncbi.nlm.nih.gov/26627107

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Racial/ethnic disparities in HIV diagnoses among persons aged 50 years and older in 37 US States, 2005-2008

1 reference

https://pubmed.ncbi.nlm.nih.gov/26627107

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comments on 'KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease'

1 reference

https://pubmed.ncbi.nlm.nih.gov/26627107

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Stribild® (elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate): a new paradigm for HIV-1 treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/26627107

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1097/QAI.0000000000000908

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36721012&oldid=2135228717"